Elsevier

Oral Oncology

Volume 43, Issue 2, February 2007, Pages 187-192
Oral Oncology

Smoking has a negative impact upon health related quality of life after treatment for head and neck cancer

https://doi.org/10.1016/j.oraloncology.2006.02.006Get rights and content

Summary

To examine the influence of smoking on observer based morbidity scores and patient assessed health related quality of life after treatment for head and neck cancer. The results of EORTC C30 and H&N35 questionnaires and DAHANCA morbidity scores were studied according to smoking status in 114 recurrence free head and neck cancer patients. In contrast to observer based toxicity scoring, smoking had a significantly negative influence on 20 of the 33 quality of life scales. Previous smokers had quality of life scores in between never smokers and continuous smokers. Smoking after treatment of head and neck cancer adversely influenced a wide range of quality of life endpoints. Quitters had better quality of life than patients who continued to smoke after treatment, suggesting that smoking cessation may improve quality of life in addition to reducing the risk of new cancer.

Introduction

Smoking is a prevalent addictive behaviour with major implications on mortality and morbidity in all countries. It is the second major cause of death worldwide and is responsible for the death of 1 in 10 adults worldwide [www.who.int]. Tobacco is an important risk factor in the development of squamous cell head and neck cancer. Additionally, smoking decreases the effect of radiotherapy1, 2 and increases the rate of second primaries.3

The influence of smoking on radiotherapy side effects has only been sparsely studied. Smoking has been reported to lead to excess duration of mucositis in radiotherapy using the CHART schedule4 and increased severity of mucositis and acute skin reaction also in a more heterogeneous population of head and neck cancer patients.5 However, in another study, including 115 head and neck cancer patients receiving radiotherapy with or without chemotherapy, no influence was found of smoking on acute radiotherapy side effects.1 Smoking has been associated with late radiation induced toxicity of the lung,6 small bowel, rectum and bladder.7

A significant number of patients continue to smoke after diagnosis and definitive therapy. Smokers associate their habit with pleasure and relaxation. A few studies have suggested, however, that smoking is associated with decreased quality of life (QoL) in a general population,8 in survivors of lung cancer9 and head and neck cancer patients with non-terminal disease.10 The aim of the present study was to estimate the influence of continued smoking and smoking cessation, respectively, on observer-assessed morbidity and self-reported overall and tumour site specific QoL in a population of recurrence free head and neck cancer patients.

Section snippets

Patients and methods

Patients in follow-up after radical radiotherapy or surgery for larynx, pharynx and oral cavity cancer were candidates for the study. The study set-up has been described in detail previously.11 In brief, consecutive eligible patients were asked to fill out the EORTC quality of life questionnaires (QLQ) C30 and H&N35, which have recently been validated in Danish.11 Exclusion criteria’s, applied before asking the patient to participate, were previously determined recurrences (57 patients) and

Results

At the time of follow-up there were 62 non-smokers and 52 smokers. Smoking status was independent of all registered clinical parameters as: age (at study time), PS, gender, stage, site, treatment modality or time since treatment. Patients who were smokers at follow-up invariably had the lowest function scores and the highest symptoms scores in both DAHANCA and EORTC QLQ except for FIBROSIS and HN Weight gain. The difference between smokers and non-smokers were significant (p < 0.05) in 20 of the

Discussion

In the present study we compared morbidity and quality of life between smokers and non-smokers in a population of 114 recurrence free head and neck cancer patients. The analysis clearly demonstrated that patients who continued smoking after diagnosis and treatment had poorer quality of life compared to quitters and never smokers. Smoking negatively influenced much wider range of QOL endpoints than well-known clinical parameters like performance status, stage, treatment etc. The statistically

Conclusion

Continued smoking after treatment of head and neck cancer adversely influenced a wide range of quality of life endpoints, of which many were apparently unrelated to the direct effect of smoking on the upper aero-digestive tract and lungs. Quitters had better quality of life than patients who continued to smoke after treatment, suggesting that smoking cessation may improve quality of life in addition to reducing the risk of new cancer.

Acknowledgements

The authors would like to thank the Danish Cancer Society Grant DP 03 112, Radiumstationens Forskningsfond, Agnes Niebuhr Anderssons Fond and William Nielsens Mindefond for financial support.

References (27)

  • K.A. Do et al.

    Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies

    Cancer

    (2004)
  • T. Rugg et al.

    Smoking and mucosal reactions to radiotherapy

    Br J Radiol

    (1990)
  • D. Porock et al.

    The relationship between factors that impair wound healing and the severity of acute radiation skin and mucosal toxicities in head and neck cancer

    Cancer Nurs

    (2004)
  • Cited by (59)

    • The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis

      2019, Radiotherapy and Oncology
      Citation Excerpt :

      This was further supported in a study by Jensen et al. which demonstrated that patients who continued smoking had a lower QoL than those who ceased. However, this paper did not meet eligibility criteria due to the inclusion of surgical patients [42]. The correlation between continued smoking and late but not acute toxicities may suggest that the negative effects of smoking are time dependent.

    • Improvements in health-related quality of life among smokers who quit after hospitalization

      2018, Preventive Medicine
      Citation Excerpt :

      Others are quite small with sample sizes under 100 (Rungruanghiranya et al., 2008; Balduyck et al., 2011; Sales et al., 2009; Erickson et al., 2004; Zillich et al., 2002). Some have specifically followed smokers who either quit or continued smoking during the observation period, or compared post-cessation quality of life for the two groups, but did not compare changes in quality of life from baseline (Sales et al., 2009; Guitérrez-Bedmar et al., 2009; Jensen et al., 2007). And some studies assessed changes in quality of life for smokers who quit, but did not include control groups of smokers who continued smoking (Sales et al., 2009; Erickson et al., 2004; Zillich et al., 2002; Papadopoulos et al., 2011).

    View all citing articles on Scopus
    View full text